Dr. Reddy's Laboratories quarterly results ending 31-Dec-2024 - 

Revenue at 8,531.4Cr vs 7,453Cr
PBT at 1,870.1Cr vs 1,826.4Cr
PAT at 1,404.2Cr vs 1,380.9Cr
EBITDA at 2,273Cr vs 2,023.1Cr
EBITDA Margin at 27.12% vs 27.96%
EPS at 16.94 vs 82.81

#DRREDDY
#DRREDDY